MicroRNA expression profiling in multidrug resistance of the 5-Fu-induced SGC-7901 human gastric cancer cell line

Molecular Medicine Reports

Volumn 7, Issue 5, 2013, Pages 1506-1510

  Wang, Yan ^a   Gu, Xiaodong ^a   Li, Zhenyang ^a   Xiang, Jianbin ^a   Jiang, Jianhai ^b   Chen, Zongyou ^a  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Gastric cancer; MicroRNA; Multidrug resistance

Indexed keywords

FLUOROURACIL; MICRORNA; MICRORNA 10B; MICRORNA 1229; MICRORNA 1238; MICRORNA 1244 3P; MICRORNA 1273D; MICRORNA 133B; MICRORNA 1728 3P; MICRORNA 190; MICRORNA 197; MICRORNA 210; MICRORNA 22; MICRORNA 31; MICRORNA 3126 3P; MICRORNA 3131; MICRORNA 3149; MICRORNA 32; MICRORNA 4701 5P; MICRORNA 4763 3P; MICRORNA 486 3P; MICRORNA 501; MICRORNA 504 5P; MICRORNA 5096; MICRORNA 532; MICRORNA 615; MICRORNA 615 5P; MICRORNA 766; MICRORNA 877; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; UPREGULATION; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE, TUMOR; CELL SHAPE; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FLUOROURACIL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INHIBITORY CONCENTRATION 50; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; P-GLYCOPROTEIN; REAL-TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; STOMACH NEOPLASMS;

EID: 84875984235     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1384     Document Type: Article

References (27)

1. Zhao P, Dai M, Chen W and Li N: Cancer trends in China. Jpn J Clin Oncol 40: 281-285, 2010.
2. Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2008. CA Cancer J Clin 58: 71-96, 2008.
3. de Bree E, Charalampakis V, Melissas J and Tsiftsis DD: The extent of lymph node dissection for gastric cancer: a critical appraisal. J Surg Oncol 102: 552-562, 2010.
4. Lagos-Quintana M, Rauhut R, Lendeckel W and Tuschl T: Identification of novel genes coding for small expressed RNAs. Science 294 : 853-858, 2001.
5. Cheng AM, Byrom MW, Shelton J and Ford LP: Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res 33: 1290-1297, 2005.
6. Blower PE, Chung JH, Verducci JS, et al: MicroRNAs modulate the chemosensitivity of tumor cells. Mol Cancer Ther 7: 1-9, 2008.
7. Zheng T, Wang J, Chen X and Liu L: Role of microRNA in anticancer drug resistance. Int J Cancer 126: 2-10, 2010.
8. Sarkar FH, Li Y, Wang Z, Kong D and Ali S: Implication of microRNAs in drug resistance for designing novel cancer therapy. Drug Resist Updat 13: 57-66, 2010.
9. Rossi L, Bonmassar E and Faraoni I: Modification of miR gene expression pattern in human colon cancer cells following exposure to 5-fluorouracil in vitro. Pharmacol Res 56: 248-253, 2007.
10. Nakajima G, Hayashi K, Xi Y, et al: Non-coding microRNAs hsa-let-7g and hsa-miR-181b are associated with chemoresponse to S-1 in colon cancer. Cancer Genomics Proteomics 3: 317-324, 2006.
11. Rosenfeld N, Aharonov R, Meiri E, et al: MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol 26: 462-469, 2008.
12. Schmittgen TD, Lee EJ, Jiang J, et al: Real-time PCR quantification of precursor and mature microRNA. Methods 44: 31-38, 2008.
13. Luqmani YA: Mechanisms of drug resistance in cancer chemotherapy. Med Princ Pract 14 (Suppl 1): 35-48, 2005.
14. Ganguly A, Banerjee K, Chakraborty P, et al: Overcoming multidrug resistance (MDR) in cancer in vitro and in vivo by a quinoline derivative. Biomed Pharmacother 65: 387-394, 2011.
15. Gottesman MM and Pastan I: The multidrug transporter, a double-edged sword. J Biol Chem 263: 1263-1266, 1988.
16. Moscow JA and Cowan KH: Multidrug resistance. J Natl Cancer Inst 80: 14-20, 1988.
17. Watson MB, Lind MJ and Cawkwell L: Establishment of in-vitro models of chemotherapy resistance. Anticancer Drugs 18: 749-754, 2007.
18. Singh R and Lillard JW Jr: Nanoparticle-based targeted drug delivery. Exp Mol Pathol 86: 215-223, 2009.
19. Hammond SM, Bernstein E, Beach D and Hannon GJ: An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature 404: 293-296, 2000.
20. Fujita Y, Kojima K, Hamada N, et al: Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells. Biochem Biophys Res Commun 377: 114-119, 2008.
21. Northcott PA, Fernandez-L A, Hagan JP, et al: The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors. Cancer Res 69: 3249-3255, 2009.
22. Li Y, Li W, Yang Y, et al: MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiforme. Brain Res 1286: 13-18, 2009.
23. Xia L, Zhang D, Du R, et al: miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int J Cancer 123: 372-379, 2008.
24. Ma L, Teruya-Feldstein J and Weinberg RA: Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449: 682-688, 2007.
25. Gee HE, Camps C, Buffa FM, et al: MicroRNA-10b and breast cancer metastasis. Nature 455: E8-E9, 2008.
26. Li G, Wu Z, Peng Y, et al: MicroRNA-10b induced by Epstein-Barr virus-encoded latent membrane protein-1 promotes the metastasis of human nasopharyngeal carcinoma cells. Cancer Lett 299: 29-36, 2010.
27. Kakarala M, Brenner DE, Korkaya H, et al: Targeting breast stem cells with the cancer preventive compounds curcumin and piperine. Breast Cancer Res Treat 122: 777-785, 2010.